Home Blog Page 2
Diseased colon, illustration
AbbVie will acquire Landos, which is focused on the development of novel, oral therapeutics for autoimmune diseases. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist.
Agena Bioscience and N-of-One will partner to offer interpretation of cancer genomic data generated by Agena’s MassARRAY® System. [Source: iStock/© agsandrew]
Artificial Intelligence has enhanced personal health outcomes by simplifying diagnosis and treatment. Recent research delves into its potential to enhance public health outcomes too. Through AI, healthcare institutions can tackle non-medical determinants impacting health. It's vital for medical ethics policies to evolve alongside these technologies, ensuring continuous evaluation of models for biases and data inconsistencies.
Digital Brain hovering above a series of computer chips to illustrate artificial intelligence (AI)-powered tools to help patients.
An AI-driven early warning tool can help predict which hospitalized patients are about to deteriorate and allow them to get fast treatment.
Colon cancer. Cancer attacking cell. Colon disease concept
A gene known to cause colorectal cancer may also play a role in the development of other solid tumors, according to a large study.
Lung cancer, close-up
A nearly 10-year-old Medicare policy that was enacted to encourage the use of lung cancer screening in patients with comorbidities needs major changes to improve patient-provider shared decision making.
Older female patient lying in hospital bed to represent misdiagnosis of community-acquired pneumonia
Around 12 percent of hospitalized individuals are regularly misdiagnosed with community-acquired pneumonia and given unnecessary antibiotics.
psoriasis on a mid age mans  elbow
A team of investigators from The Australian National University (ANU) say they have discovered a gene mutation that is responsible for causing psoriasis, the chronic inflammatory disease that results in red, scaly, itchy patches on the skin.
immune system
Mirador Therapeutics has launched with more than $400 million with the aim to “revolutionize precision medicine for immune-mediated inflammatory and fibrotic diseases.”
Cell division
A tiny, battery-free magnetic implant that works with a wearable device has shown promise for advanced, long-term health monitoring, early research shows.
Nerve cells affected by Alzheimer's disease, illustration
Researchers have identified two proteins that affect the functioning of immune cells called macrophages in lipid-rich tissue, a finding that deepens the understanding of Alzheimer’s disease (AD) and could provide new targets for treatments.

Related Content

Inside Precision Medicine